Insulet Corp logo

Insulet (PODD) — Congressional Trading Activity

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Members Trading

6

All-time in Insulet

Buyers vs Sellers

1Buyers/1Sellers

Members buying vs selling · last 90 days

Trades (90d)

3

Disclosed in the last 90 days

Avg Member Return

+1.5%

Top performers, TTM

Stock Report
$1K - $15K
StockPurchaseDemocratCaliforniaNov 10, 2026Oct 20, 2026House
$1K - $15K
StockSale (Partial)DemocratCaliforniaOct 12, 2026Sep 18, 2026House
$1K - $15K
StockPurchaseDemocratCaliforniaSep 10, 2026Aug 18, 2026House
$100K - $250K
StockSaleDemocratMinnesotaMay 10, 2026May 07, 2026Senate
$100K - $250K
StockSale (Partial)DemocratMinnesotaMay 10, 2026Apr 29, 2026Senate
$1K - $15K
StockSaleRepublicanOklahomaAug 12, 2025Jan 04, 2024Senate
$1K - $15K
StockPurchaseRepublicanOklahomaJul 30, 2025Jan 03, 2023Senate
$50K - $100K
StockSale (Partial)DemocratMinnesotaApr 19, 2024Apr 04, 2024Senate
$1K - $15K
StockSale (Partial)RepublicanOklahomaJan 26, 2024Dec 22, 2023Senate
$1K - $15K
StockSaleDemocratNew YorkAug 13, 2023Jul 12, 2023House